Fluicell AB (FLUI) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.017x

Based on the latest financial reports, Fluicell AB (FLUI) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr248.00K ≈ $26.69K USD) by net assets (Skr14.21 Million ≈ $1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Fluicell AB net asset quality index to measure how much of total assets are equity-financed.

Fluicell AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Fluicell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check FLUI operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Fluicell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fluicell AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pulse Oil Corp V:PUL	0.019x
Catalina Resources Ltd AU:CTN	-0.160x
Terra Uranium Ltd AU:T92	-0.053x
Sagardeep Alloys Limited NSE:SAGARDEEP	-0.207x
Raja Ferry Port Public Company Limited BK:RP	0.059x
Green Ocean Corporation Bhd KLSE:0074	0.002x
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares NASDAQ:HKPD	-0.018x
Dotz Nano Ltd F:57N	0.323x

Annual Cash Flow Conversion Efficiency for Fluicell AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of Fluicell AB from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Fluicell AB worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr10.90 Million ≈ $1.17 Million	Skr-4.95 Million ≈ $-532.16K	-0.454x	+44.32%
2024-12-31	Skr19.23 Million ≈ $2.07 Million	Skr-15.67 Million ≈ $-1.69 Million	-0.815x	+98.73%
2023-12-31	Skr425.00K ≈ $45.74K	Skr-27.23 Million ≈ $-2.93 Million	-64.064x	-7037.92%
2022-12-31	Skr23.45 Million ≈ $2.52 Million	Skr-21.04 Million ≈ $-2.26 Million	-0.898x	+7.98%
2021-12-31	Skr19.11 Million ≈ $2.06 Million	Skr-18.64 Million ≈ $-2.01 Million	-0.975x	-8.24%
2020-12-31	Skr19.50 Million ≈ $2.10 Million	Skr-17.57 Million ≈ $-1.89 Million	-0.901x	+46.02%
2019-12-31	Skr10.22 Million ≈ $1.10 Million	Skr-17.07 Million ≈ $-1.84 Million	-1.669x	-213.09%
2018-12-31	Skr23.37 Million ≈ $2.52 Million	Skr-12.46 Million ≈ $-1.34 Million	-0.533x	+34.76%
2017-12-31	Skr9.58 Million ≈ $1.03 Million	Skr-7.83 Million ≈ $-842.74K	-0.817x	+72.63%
2016-12-31	Skr1.84 Million ≈ $198.12K	Skr-5.50 Million ≈ $-591.56K	-2.986x	--

About Fluicell AB

ST:FLUI Sweden Biotechnology

Market Cap

$4.51 Million

Skr41.90 Million SEK

Market Cap Rank

#28743 Global

#651 in Sweden

Share Price

Skr30.50

Change (1 day)

-1.93%

52-Week Range

Skr7.95 - Skr57.20

All Time High

Skr188.78